We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$1.09B
AUM Growth
+$83.5M
Cap. Flow
+$4.47M
Cap. Flow %
0.41%
Top 10 Hldgs %
89.8%
Holding
226
New
28
Increased
13
Reduced
39
Closed
82

Sector Composition

Rank Sector Weight
1 Technology 1.79%
2 Financials 0.79%
3 Healthcare 0.56%
4 Industrials 0.51%
5 Communication Services 0.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GCI
226
DELISTED
Gannett Co., Inc
GCI
-256
Closed -$2K

Similar funds

Hirtle Callaghan & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Hirtle Callaghan & Co held 226 positions worth $1.09B, up 8.3% from $1.01B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Hirtle Callaghan & Co's Q4 2017 filing shows 28 new, 13 increased, 39 reduced and 82 closed positions. Its largest new stake was Vanguard Growth ETF: 16,002 shares worth $375K. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.44M.

By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.8% a quarter earlier, followed by Financials and Healthcare.

  • Hirtle Callaghan & Co's largest Q4 2017 buy was Vanguard Growth ETF: 16,002 shares worth $375K.
  • Hirtle Callaghan & Co added most to iShares Russell 1000 Value ETF in Q4 2017, an estimated $4.1M increase.
  • Hirtle Callaghan & Co's biggest Q4 2017 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.44M.
  • Hirtle Callaghan & Co fully exited Alerian MLP ETF in Q4 2017, selling an estimated $143K.
  • Hirtle Callaghan & Co's ten largest holdings make up 90% of its $1.09B portfolio in Q4 2017.
  • Hirtle Callaghan & Co opened 28 new positions and closed 82 in Q4 2017.
  • Hirtle Callaghan & Co's portfolio value rose 8.3% quarter-over-quarter to $1.09B.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2017, filed 17 Jan 2018.